Can UVA-light-activated riboflavin-induced collagen crosslinking be transferred from ophthalmology to spine surgery? A feasibility study on bovine intervertebral disc.
<h4>Background</h4>Collagen cross-links contribute to the mechanical resilience of the intervertebral disc (IVD). UVA-light-activated riboflavin-induced collagen crosslinking (UVA-CXL) is a well-established and effective ophthalmological intervention that increases the mechanical rigidit...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6355eb61a44b49e3800ffe984bf24257 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6355eb61a44b49e3800ffe984bf24257 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6355eb61a44b49e3800ffe984bf242572021-12-02T20:11:04ZCan UVA-light-activated riboflavin-induced collagen crosslinking be transferred from ophthalmology to spine surgery? A feasibility study on bovine intervertebral disc.1932-620310.1371/journal.pone.0252672https://doaj.org/article/6355eb61a44b49e3800ffe984bf242572021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0252672https://doaj.org/toc/1932-6203<h4>Background</h4>Collagen cross-links contribute to the mechanical resilience of the intervertebral disc (IVD). UVA-light-activated riboflavin-induced collagen crosslinking (UVA-CXL) is a well-established and effective ophthalmological intervention that increases the mechanical rigidity of the collagen-rich corneal matrix in Keratoconus. This study explores the feasibility, safety and efficacy of translating this intervention in reinforcing the IVD.<h4>Methods</h4>Annulus fibrosus (AF) cells were isolated from bovine IVDs and treated with different combinations of riboflavin (RF) concentrations (0.05-8 mM) and UVA light intensities (0.3-4 mW/cm2). Metabolic activity (resazurin assay), cell viability (TUNEL assay), and gene expression of apoptosis regulators C-FOS and PT5 were assessed immediately and 24 hours after treatment. Biomechanical effects of UVA-CXL on IVDs were measured by indentation analysis of changes in the instantaneous modulus and by peel-force delamination strength analysis of the AF prior and after treatment.<h4>Results</h4>Different intensities of UVA did not impair the metabolic activity of AF cells. However, RF affected metabolic activity (p < 0.001). PT53 expression was similar in all RF conditions tested while C-FOS expression decreased 24 hours after treatment. Twenty-four hours after treatment, no apoptotic cells were observed in any condition tested. Biomechanical characterizations showed a significant increase in the annular peel strength of the UVA-CXL group, when compared to controls of UVA and RF alone (p < 0.05). UVA-CXL treated IVDs showed up to 152% higher (p < 0.001) instantaneous modulus values compared to the untreated control.<h4>Conclusion</h4>This is the first study on UVA-CXL treatment of IVD. It induced significantly increased delamination strength and instantaneous modulus indentation values in intact IVD samples in a structure-function relationship. RF concentrations and UVA intensities utilized in ophthalmological clinical protocols were well tolerated by the AF cells. Our findings suggest that UVA-CXL may be a promising tool to reinforce the IVD matrix.Ioannis VasilikosGraciosa Q TeixeiraAndreas SeitzJulia NothelferJulian HaasHans-Joachim WilkeBoris MizaikoffJürgen BeckUlrich HubbeCornelia Neidlinger-WilkePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0252672 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Ioannis Vasilikos Graciosa Q Teixeira Andreas Seitz Julia Nothelfer Julian Haas Hans-Joachim Wilke Boris Mizaikoff Jürgen Beck Ulrich Hubbe Cornelia Neidlinger-Wilke Can UVA-light-activated riboflavin-induced collagen crosslinking be transferred from ophthalmology to spine surgery? A feasibility study on bovine intervertebral disc. |
description |
<h4>Background</h4>Collagen cross-links contribute to the mechanical resilience of the intervertebral disc (IVD). UVA-light-activated riboflavin-induced collagen crosslinking (UVA-CXL) is a well-established and effective ophthalmological intervention that increases the mechanical rigidity of the collagen-rich corneal matrix in Keratoconus. This study explores the feasibility, safety and efficacy of translating this intervention in reinforcing the IVD.<h4>Methods</h4>Annulus fibrosus (AF) cells were isolated from bovine IVDs and treated with different combinations of riboflavin (RF) concentrations (0.05-8 mM) and UVA light intensities (0.3-4 mW/cm2). Metabolic activity (resazurin assay), cell viability (TUNEL assay), and gene expression of apoptosis regulators C-FOS and PT5 were assessed immediately and 24 hours after treatment. Biomechanical effects of UVA-CXL on IVDs were measured by indentation analysis of changes in the instantaneous modulus and by peel-force delamination strength analysis of the AF prior and after treatment.<h4>Results</h4>Different intensities of UVA did not impair the metabolic activity of AF cells. However, RF affected metabolic activity (p < 0.001). PT53 expression was similar in all RF conditions tested while C-FOS expression decreased 24 hours after treatment. Twenty-four hours after treatment, no apoptotic cells were observed in any condition tested. Biomechanical characterizations showed a significant increase in the annular peel strength of the UVA-CXL group, when compared to controls of UVA and RF alone (p < 0.05). UVA-CXL treated IVDs showed up to 152% higher (p < 0.001) instantaneous modulus values compared to the untreated control.<h4>Conclusion</h4>This is the first study on UVA-CXL treatment of IVD. It induced significantly increased delamination strength and instantaneous modulus indentation values in intact IVD samples in a structure-function relationship. RF concentrations and UVA intensities utilized in ophthalmological clinical protocols were well tolerated by the AF cells. Our findings suggest that UVA-CXL may be a promising tool to reinforce the IVD matrix. |
format |
article |
author |
Ioannis Vasilikos Graciosa Q Teixeira Andreas Seitz Julia Nothelfer Julian Haas Hans-Joachim Wilke Boris Mizaikoff Jürgen Beck Ulrich Hubbe Cornelia Neidlinger-Wilke |
author_facet |
Ioannis Vasilikos Graciosa Q Teixeira Andreas Seitz Julia Nothelfer Julian Haas Hans-Joachim Wilke Boris Mizaikoff Jürgen Beck Ulrich Hubbe Cornelia Neidlinger-Wilke |
author_sort |
Ioannis Vasilikos |
title |
Can UVA-light-activated riboflavin-induced collagen crosslinking be transferred from ophthalmology to spine surgery? A feasibility study on bovine intervertebral disc. |
title_short |
Can UVA-light-activated riboflavin-induced collagen crosslinking be transferred from ophthalmology to spine surgery? A feasibility study on bovine intervertebral disc. |
title_full |
Can UVA-light-activated riboflavin-induced collagen crosslinking be transferred from ophthalmology to spine surgery? A feasibility study on bovine intervertebral disc. |
title_fullStr |
Can UVA-light-activated riboflavin-induced collagen crosslinking be transferred from ophthalmology to spine surgery? A feasibility study on bovine intervertebral disc. |
title_full_unstemmed |
Can UVA-light-activated riboflavin-induced collagen crosslinking be transferred from ophthalmology to spine surgery? A feasibility study on bovine intervertebral disc. |
title_sort |
can uva-light-activated riboflavin-induced collagen crosslinking be transferred from ophthalmology to spine surgery? a feasibility study on bovine intervertebral disc. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/6355eb61a44b49e3800ffe984bf24257 |
work_keys_str_mv |
AT ioannisvasilikos canuvalightactivatedriboflavininducedcollagencrosslinkingbetransferredfromophthalmologytospinesurgeryafeasibilitystudyonbovineintervertebraldisc AT graciosaqteixeira canuvalightactivatedriboflavininducedcollagencrosslinkingbetransferredfromophthalmologytospinesurgeryafeasibilitystudyonbovineintervertebraldisc AT andreasseitz canuvalightactivatedriboflavininducedcollagencrosslinkingbetransferredfromophthalmologytospinesurgeryafeasibilitystudyonbovineintervertebraldisc AT julianothelfer canuvalightactivatedriboflavininducedcollagencrosslinkingbetransferredfromophthalmologytospinesurgeryafeasibilitystudyonbovineintervertebraldisc AT julianhaas canuvalightactivatedriboflavininducedcollagencrosslinkingbetransferredfromophthalmologytospinesurgeryafeasibilitystudyonbovineintervertebraldisc AT hansjoachimwilke canuvalightactivatedriboflavininducedcollagencrosslinkingbetransferredfromophthalmologytospinesurgeryafeasibilitystudyonbovineintervertebraldisc AT borismizaikoff canuvalightactivatedriboflavininducedcollagencrosslinkingbetransferredfromophthalmologytospinesurgeryafeasibilitystudyonbovineintervertebraldisc AT jurgenbeck canuvalightactivatedriboflavininducedcollagencrosslinkingbetransferredfromophthalmologytospinesurgeryafeasibilitystudyonbovineintervertebraldisc AT ulrichhubbe canuvalightactivatedriboflavininducedcollagencrosslinkingbetransferredfromophthalmologytospinesurgeryafeasibilitystudyonbovineintervertebraldisc AT cornelianeidlingerwilke canuvalightactivatedriboflavininducedcollagencrosslinkingbetransferredfromophthalmologytospinesurgeryafeasibilitystudyonbovineintervertebraldisc |
_version_ |
1718374949405589504 |